Arteris (NASDAQ:AIP) Rating Reiterated by Wedbush

Arteris (NASDAQ:AIP – Get Free Report)‘s stock had its “outperform” rating reissued by investment analysts at Wedbush in a report released on Tuesday, Benzinga reports. They currently have a $17.00 target price on the stock. Wedbush’s target price would indicate a potential upside of 147.81% from the stock’s previous close. Arteris Price Performance Shares of […]

Leave a Reply

Your email address will not be published.

Previous post Alnylam Pharmaceuticals (NASDAQ:ALNY) Given Neutral Rating at Cantor Fitzgerald
Next post How Do Attorneys Assist in Maximizing Your Recovery After a Hit and Run?